首页 > 最新文献

Harvard Journal of Legislation最新文献

英文 中文
Strategies of Public UDAP Enforcement 公共UDAP执行策略
Q3 Social Sciences Pub Date : 2017-03-30 DOI: 10.2139/SSRN.2942406
Prentiss Cox, Amy Widman, Mark D. Totten
Laws protecting consumers from unfair and deceptive acts and practices – commonly called “UDAP” laws – have played a stunning role in recent years. As one example, state and federal enforcers plied these laws more than any other to hold individuals and companies accountable for the Great Recession, while chalking-up record payouts. And with the shift in national power, the spotlight shows no signs of dimming. Given the outsized role these statutes play, critics have directed their sights on both the laws and the enforcers who wield them. Missing from this debate, however, is an account of the actual conduct of UDAP enforcement in America. How do public UDAP enforcers exercise their considerable discretion? This article examines every UDAP matter resolved by state and federal enforcers in 2014 and presents the initial results of the first comprehensive empirical study of public UDAP enforcement. Across a range of attributes, public UDAP enforcement varies while also revealing clear patterns. We organize the data to show how enforcers employ distinct strategies. The two main federal enforcers adopt sharply different approaches, especially regarding targets and relief. The state enforcers divide into seven distinct strategies, distinguished not only by case variables, but also by case quantity and leadership in multi-enforcer actions. The picture that emerges should shape the policy and scholarly debate on public UDAP enforcement and help optimize the work of public enforcers.
保护消费者免受不公平和欺骗性行为和做法侵害的法律——通常被称为“UDAP”法律——近年来发挥了惊人的作用。例如,州和联邦执法者比任何其他执法者都更严格地执行这些法律,要求个人和公司对大衰退负责,同时创下了支出记录。随着国家权力的转移,聚光灯没有变暗的迹象。鉴于这些法规所发挥的巨大作用,批评者将目光投向了法律和执行者。然而,这场辩论中缺少对美国UDAP执法实际情况的描述。公共UDAP执法者如何行使其相当大的自由裁量权?本文考察了州和联邦执法者在2014年解决的每一个UDAP问题,并介绍了首次对公共UDAP执法进行全面实证研究的初步结果。在一系列属性中,公共UDAP强制执行各不相同,同时也揭示了明确的模式。我们对数据进行整理,以显示执法者如何使用不同的策略。两个主要的联邦执法者采取了截然不同的方法,尤其是在目标和救济方面。国家执法者分为七种不同的策略,不仅通过案例变量来区分,还通过案例数量和多执法者行动中的领导力来区分。出现的情况应该会影响关于公共UDAP执法的政策和学术辩论,并有助于优化公共执法者的工作。
{"title":"Strategies of Public UDAP Enforcement","authors":"Prentiss Cox, Amy Widman, Mark D. Totten","doi":"10.2139/SSRN.2942406","DOIUrl":"https://doi.org/10.2139/SSRN.2942406","url":null,"abstract":"Laws protecting consumers from unfair and deceptive acts and practices – commonly called “UDAP” laws – have played a stunning role in recent years. As one example, state and federal enforcers plied these laws more than any other to hold individuals and companies accountable for the Great Recession, while chalking-up record payouts. And with the shift in national power, the spotlight shows no signs of dimming. Given the outsized role these statutes play, critics have directed their sights on both the laws and the enforcers who wield them. Missing from this debate, however, is an account of the actual conduct of UDAP enforcement in America. How do public UDAP enforcers exercise their considerable discretion? This article examines every UDAP matter resolved by state and federal enforcers in 2014 and presents the initial results of the first comprehensive empirical study of public UDAP enforcement. Across a range of attributes, public UDAP enforcement varies while also revealing clear patterns. We organize the data to show how enforcers employ distinct strategies. The two main federal enforcers adopt sharply different approaches, especially regarding targets and relief. The state enforcers divide into seven distinct strategies, distinguished not only by case variables, but also by case quantity and leadership in multi-enforcer actions. The picture that emerges should shape the policy and scholarly debate on public UDAP enforcement and help optimize the work of public enforcers.","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":"55 1","pages":"37-104"},"PeriodicalIF":0.0,"publicationDate":"2017-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48040747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Of Death and Deadlocks: Section 4 of the Twentieth Amendment 死亡和僵局:第二十修正案第四节
Q3 Social Sciences Pub Date : 2016-04-12 DOI: 10.2139/SSRN.2635633
B. Kalt
When no presidential candidate wins a majority in the electoral college, the House of Representatives holds a “contingent election” between the top three candidates. Unfortunately, if one of those three candidates should die there is no way to provide a substitute, so the dead candidate’s supporters and party would be disenfranchised.Section 4 of the Twentieth Amendment, ratified in 1933, addressed this situation; it authorized Congress to legislate a process for substituting a new candidate. But for eighty-three years Congress (along with scholars) has never seriously considered Section 4 — let alone passed legislation under it. This neglect has fostered a dangerous incentive for assassination in the presidential electoral system. In every other stage in the process, dead candidates can be replaced; only here can an assassin eliminate an entire party from consideration in the election. A contingent election would be dramatic enough as it is; without Section 4 legislation, a candidate’s death could turn the election from a drama into a disaster.Part I of this Article provides context and background on Section 4. Part II considers what Congress should provide if it ever enacts Section 4 legislation and concludes with draft legislation. Part III briefly considers why Congress has failed for so long to use its Section 4 power.
当没有总统候选人在选举人团中赢得多数时,众议院就会在得票最多的三名候选人之间举行“临时选举”。不幸的是,如果这三位候选人中的一位去世,就没有办法提供替代人选,因此,已故候选人的支持者和政党将被剥夺公民权。1933年批准的《第二十修正案》第四节处理了这种情况;它授权国会立法制定替代新候选人的程序。但83年来,国会(连同学者们)从未认真考虑过第4条,更不用说根据它通过立法了。这种忽视助长了总统选举制度中暗杀的危险动机。在这个过程的其他阶段,死亡的候选人可以被替换;只有在这种情况下,刺客才能将整个政党排除在选举之外。临时选举本身就已经足够戏剧性了;如果没有第4条立法,候选人的死亡可能会使选举从戏剧变成灾难。本文的第一部分提供了第4节的上下文和背景。第二部分考虑如果国会颁布第四节立法,国会应该提供什么,并以立法草案结束。第三部分简要地考虑了为什么国会这么长时间没有使用第四节的权力。
{"title":"Of Death and Deadlocks: Section 4 of the Twentieth Amendment","authors":"B. Kalt","doi":"10.2139/SSRN.2635633","DOIUrl":"https://doi.org/10.2139/SSRN.2635633","url":null,"abstract":"When no presidential candidate wins a majority in the electoral college, the House of Representatives holds a “contingent election” between the top three candidates. Unfortunately, if one of those three candidates should die there is no way to provide a substitute, so the dead candidate’s supporters and party would be disenfranchised.Section 4 of the Twentieth Amendment, ratified in 1933, addressed this situation; it authorized Congress to legislate a process for substituting a new candidate. But for eighty-three years Congress (along with scholars) has never seriously considered Section 4 — let alone passed legislation under it. This neglect has fostered a dangerous incentive for assassination in the presidential electoral system. In every other stage in the process, dead candidates can be replaced; only here can an assassin eliminate an entire party from consideration in the election. A contingent election would be dramatic enough as it is; without Section 4 legislation, a candidate’s death could turn the election from a drama into a disaster.Part I of this Article provides context and background on Section 4. Part II considers what Congress should provide if it ever enacts Section 4 legislation and concludes with draft legislation. Part III briefly considers why Congress has failed for so long to use its Section 4 power.","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":"54 1","pages":"101"},"PeriodicalIF":0.0,"publicationDate":"2016-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68234523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Neoercantilist Fallacy and the Contextual Reality of the Foreign Corrupt Practices Act 新政治主义谬误与《反海外腐败法》的语境现实
Q3 Social Sciences Pub Date : 2015-02-20 DOI: 10.2139/SSRN.2567940
Philip M. Nichols
The Foreign Corrupt Practices Act is domestic legislation and should be analyzed as such. This article addresses a persistent failure in analysis of the Act, by scholars and policymakers alike. Many discussions of the Act approach it from a neomercantilist perspective. This approach contains three flaws. First, whereas neomercantilism envisions manipulation of the market to give advantage to national champion industries, the Foreign Corrupt Practices Act was adopted for the purpose of strengthening and enhancing the integrity of the global market. A neomercantilist perspective is contrary to the purpose of the Act. Second, this article shows that neomercantilism fundamentally misunderstands the world of business – the modern equivalent of the mercantilist fallacy. Business firms form networks of relationships with little reference to political borders, whereas neomercantilism envisions a world in which business firms are siloed by national borders. By importing this fallacy, a neomercantilist perspective invariably yields a flawed analysis. Third, Congress asked that the Foreign Corrupt Practices Act become part of a global anticorruption regime, and that request has been robustly answered. By its own definitions the Act applies only to business actors engaged in transnational activities. These business actors will also be subject to the other elements of the global regime, as will their competitors. Neomercantilism cannot account for the Act’s place in that regime. Legal analysis in general has difficulty in accounting for domestic business regulations that encompass transnational behavior. Law must overcome this difficulty or it risks becoming irrelevant to business. Analysis of the Foreign Corrupt Practices Act must avoid the neomercantilist approach, not just for the sake of intellectual rigor, but also to accrue the benefits of a sound market as envisioned by Congress.
《反海外腐败法》是国内法,应该作为国内法来分析。本文解决了学者和政策制定者对该法案的分析中持续存在的失败。许多关于该法案的讨论都是从新重商主义的角度出发的。这种方法有三个缺陷。首先,虽然新重商主义设想操纵市场以使国家冠军产业受益,但《反海外腐败法》的通过是为了加强和提高全球市场的完整性。新重商主义的观点与该法案的目的背道而驰。其次,本文表明,新重商主义从根本上误解了商业世界——相当于现代的重商主义谬误。商业公司形成的关系网络很少涉及政治边界,而新重商主义设想了一个商业公司被国界隔离的世界。通过引入这种谬论,新重商主义的观点总是产生有缺陷的分析。第三,国会要求《反海外腐败法》成为全球反腐败制度的一部分,这一要求得到了有力的回应。根据该法本身的定义,该法只适用于从事跨国活动的商业行为者。这些商业行为者也将受制于全球体制的其他要素,就像它们的竞争对手一样。新重商主义无法解释该法案在该制度中的地位。一般来说,法律分析难以解释包含跨国行为的国内商业法规。法律必须克服这一困难,否则就有可能与商业无关。对《反海外腐败法》的分析必须避免采用新重商主义的方法,这不仅是为了学术上的严谨,也是为了获得国会所设想的健全市场的好处。
{"title":"The Neoercantilist Fallacy and the Contextual Reality of the Foreign Corrupt Practices Act","authors":"Philip M. Nichols","doi":"10.2139/SSRN.2567940","DOIUrl":"https://doi.org/10.2139/SSRN.2567940","url":null,"abstract":"The Foreign Corrupt Practices Act is domestic legislation and should be analyzed as such. This article addresses a persistent failure in analysis of the Act, by scholars and policymakers alike. Many discussions of the Act approach it from a neomercantilist perspective. This approach contains three flaws. First, whereas neomercantilism envisions manipulation of the market to give advantage to national champion industries, the Foreign Corrupt Practices Act was adopted for the purpose of strengthening and enhancing the integrity of the global market. A neomercantilist perspective is contrary to the purpose of the Act. Second, this article shows that neomercantilism fundamentally misunderstands the world of business – the modern equivalent of the mercantilist fallacy. Business firms form networks of relationships with little reference to political borders, whereas neomercantilism envisions a world in which business firms are siloed by national borders. By importing this fallacy, a neomercantilist perspective invariably yields a flawed analysis. Third, Congress asked that the Foreign Corrupt Practices Act become part of a global anticorruption regime, and that request has been robustly answered. By its own definitions the Act applies only to business actors engaged in transnational activities. These business actors will also be subject to the other elements of the global regime, as will their competitors. Neomercantilism cannot account for the Act’s place in that regime. Legal analysis in general has difficulty in accounting for domestic business regulations that encompass transnational behavior. Law must overcome this difficulty or it risks becoming irrelevant to business. Analysis of the Foreign Corrupt Practices Act must avoid the neomercantilist approach, not just for the sake of intellectual rigor, but also to accrue the benefits of a sound market as envisioned by Congress.","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":"27 3 1","pages":"203"},"PeriodicalIF":0.0,"publicationDate":"2015-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68207242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lobbyists as Imperfect Agents: Implications for Public Policy in a Pluralist System 游说者作为不完美的代理人:对多元制度下公共政策的启示
Q3 Social Sciences Pub Date : 2009-01-15 DOI: 10.2139/SSRN.1331503
M. Stephenson, H. Jackson
Interest group pluralism presumes that public policy outcomes are determined principally through a contest for influence among organized pressure groups. Most interest groups, however, do not represent themselves in this process. Rather, they rely on professional lobbyists for representation, information, and advice. These lobbyists are agents with their own interests, and these interests may not align perfectly with those of their clients. This essay outlines this principal-agent problem and sketches its possible implications for policy outcomes. In particular, we hypothesize that the lobbyist-client agency problem may bias policy in favor of small homogeneous groups, may exacerbate status quo bias and lead to excessive attention to symbolic issues, may promote expansive delegations to administrative agencies, and may impede systematic reforms to the policy-making process.
利益集团多元主义假定,公共政策的结果主要是通过有组织的压力集团之间争夺影响力来决定的。然而,大多数利益集团在这一过程中并不代表自己。相反,他们依靠专业游说者提供代表、信息和建议。这些游说者是有自己利益的代理人,而这些利益可能与客户的利益并不完全一致。本文概述了这一委托代理问题,并概述了其对政策结果的可能影响。特别是,我们假设游说者-客户代理问题可能会使政策偏向于小型同质群体,可能会加剧现状偏见并导致对象征性问题的过度关注,可能会促进对行政机构的广泛授权,并可能阻碍政策制定过程的系统性改革。
{"title":"Lobbyists as Imperfect Agents: Implications for Public Policy in a Pluralist System","authors":"M. Stephenson, H. Jackson","doi":"10.2139/SSRN.1331503","DOIUrl":"https://doi.org/10.2139/SSRN.1331503","url":null,"abstract":"Interest group pluralism presumes that public policy outcomes are determined principally through a contest for influence among organized pressure groups. Most interest groups, however, do not represent themselves in this process. Rather, they rely on professional lobbyists for representation, information, and advice. These lobbyists are agents with their own interests, and these interests may not align perfectly with those of their clients. This essay outlines this principal-agent problem and sketches its possible implications for policy outcomes. In particular, we hypothesize that the lobbyist-client agency problem may bias policy in favor of small homogeneous groups, may exacerbate status quo bias and lead to excessive attention to symbolic issues, may promote expansive delegations to administrative agencies, and may impede systematic reforms to the policy-making process.","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2009-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68163908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing. 2002年儿童最佳药品法案:自愿激励结构的兴起和国会拒绝要求儿童测试。
Q3 Social Sciences Pub Date : 2003-01-01
Lauren Hammer Breslow

On January 4, 2002, President Bush signed into law the Best Pharmaceuticals for Children Act, which is the government's most comprehensive legislation regarding pediatric research to date. The Act offers pharmaceutical companies a six-month exclusivity term in return for their agreement to conduct pediatric tests on drugs. It also provides public funding and organizes private funding to help conduct pediatric research on those drugs that pharmaceutical companies opt not to test in children. This Note reviews the history of pediatric research and traces the development of the Best Pharmaceuticals for Children Act's unique incentive and public funding structure. The Note contends that, while the Act is comprehensive and promotes important pediatric studies, its incentive structure forces consumers and taxpayers to bear the costs of testing pharmaceuticals in children instead of the manufacturers who research, develop, and market those drugs. Congress should consider mandating pediatric studies in any future enactment of the legislation.

2002年1月4日,布什总统签署了《儿童最佳药品法案》,这是迄今为止政府在儿科研究方面最全面的立法。该法案为制药公司提供了6个月的排他性期限,作为他们同意进行儿科药物测试的回报。它还提供公共资金和组织私人资金,以帮助对那些制药公司选择不进行儿童试验的药物进行儿科研究。本文回顾了儿科研究的历史,并追溯了《儿童最佳药品法案》独特的激励机制和公共资助结构的发展。该报告认为,尽管该法案是全面的,并促进了重要的儿科研究,但其激励结构迫使消费者和纳税人承担在儿童身上测试药物的费用,而不是研究、开发和销售这些药物的制造商。国会应该考虑在未来的立法中授权儿科研究。
{"title":"The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.","authors":"Lauren Hammer Breslow","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>On January 4, 2002, President Bush signed into law the Best Pharmaceuticals for Children Act, which is the government's most comprehensive legislation regarding pediatric research to date. The Act offers pharmaceutical companies a six-month exclusivity term in return for their agreement to conduct pediatric tests on drugs. It also provides public funding and organizes private funding to help conduct pediatric research on those drugs that pharmaceutical companies opt not to test in children. This Note reviews the history of pediatric research and traces the development of the Best Pharmaceuticals for Children Act's unique incentive and public funding structure. The Note contends that, while the Act is comprehensive and promotes important pediatric studies, its incentive structure forces consumers and taxpayers to bear the costs of testing pharmaceuticals in children instead of the manufacturers who research, develop, and market those drugs. Congress should consider mandating pediatric studies in any future enactment of the legislation.</p>","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":" ","pages":"133-93"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25955118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protecting the right to die: the Patient Self-Determination Act of 1990. 保护死亡的权利:1990年的《病人自决法》。
Q3 Social Sciences Pub Date : 1991-01-01 DOI: 10.4324/9781315050492-6
Kelly C. Mulholland
{"title":"Protecting the right to die: the Patient Self-Determination Act of 1990.","authors":"Kelly C. Mulholland","doi":"10.4324/9781315050492-6","DOIUrl":"https://doi.org/10.4324/9781315050492-6","url":null,"abstract":"","PeriodicalId":39812,"journal":{"name":"Harvard Journal of Legislation","volume":"28 2 1","pages":"609-30"},"PeriodicalIF":0.0,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70624546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Harvard Journal of Legislation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1